Nano-X Imaging Ltd. (NNOX)
NASDAQ: NNOX · Real-Time Price · USD
5.61
-0.10 (-1.75%)
At close: May 14, 2025, 4:00 PM
5.60
-0.01 (-0.18%)
After-hours: May 14, 2025, 4:19 PM EDT
Nano-X Imaging Market Cap
Nano-X Imaging has a market cap or net worth of $357.70 million as of May 14, 2025. Its market cap has decreased by -30.60% in one year.
Market Cap
357.70M
Enterprise Value
289.08M
1-Year Change
-30.60%
Ranking
Category
Stock Price
$5.61
Market Cap Chart
Since the IPO on August 21, 2020, Nano-X Imaging's market cap has decreased from $746.15M to $357.70M, a decrease of -52.06%. That is a compound annual growth rate of -14.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 354.52M | -15.86% |
| Dec 31, 2024 | 421.36M | 14.58% |
| Dec 29, 2023 | 367.76M | -4.66% |
| Dec 30, 2022 | 385.74M | -48.67% |
| Dec 31, 2021 | 751.50M | -64.45% |
| Dec 31, 2020 | 2.11B | 183.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |